mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease.
|
27858754 |
2015 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease.
|
27858754 |
2015 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Optic Atrophy
|
0.150 |
Biomarker
|
disease |
BEFREE |
Some reported cases have been found to carry mutations in the OPA1, OPA3 or C12ORF65 genes which are known causes of pure optic atrophy or optic atrophy complicated by movement disorder.
|
26187298 |
2015 |
Movement Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Some reported cases have been found to carry mutations in the OPA1, OPA3 or C12ORF65 genes which are known causes of pure optic atrophy or optic atrophy complicated by movement disorder.
|
26187298 |
2015 |
Leigh Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Homozygous p.V116* mutation in C12orf65 results in Leigh syndrome.
|
25995486 |
2016 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Delineation of C12orf65-related phenotypes: a genotype-phenotype relationship.
|
24424123 |
2014 |
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Delineation of C12orf65-related phenotypes: a genotype-phenotype relationship.
|
24424123 |
2014 |
Optic Atrophy
|
0.150 |
Biomarker
|
disease |
BEFREE |
Our study broadens the phenotypic spectrum of C12orf65 defects and highlights the triad of optic atrophy, axonal neuropathy and spastic paraparesis as its key clinical features.
|
24424123 |
2014 |
Paraparesis, Spastic
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families.
|
24424123 |
2014 |
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families.
|
24424123 |
2014 |
Peripheral Nervous System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families.
|
24424123 |
2014 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature.
|
24284555 |
2014 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature.
|
24284555 |
2014 |
Optic Atrophy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature.
|
24284555 |
2014 |
Leigh Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We describe 2 siblings with compound heterozygous mutations in the recently identified C12orf65 gene who presented with optic atrophy and mild developmental delays and subsequently developed bilateral, symmetric lesions in the brainstem reminiscent of Leigh syndrome.
|
24284555 |
2014 |
Optic Atrophy
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We described a large consanguineous family with neuropathy and optic atrophy carrying a loss of function mutation in the C12orf65 gene.
|
24198383 |
2014 |
Axonal neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This work describes a mutation in the C12orf65 gene that causes recessive form of CMT6 and confirms the role of mitochondrial dysfunction in this complex axonal neuropathy.
|
24198383 |
2014 |
Ophthalmoplegia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Considering our findings, we now conclude that truncating mutations in C12ORF65 lead to a variable phenotype with intellectual disability, spastic paraplegia, and ophthalmoplegia as common symptoms.
|
24080142 |
2013 |
Strabismus
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Homozygosity mapping and exome sequencing in two affected siblings of a consanguineous family with mild intellectual disability, spastic paraplegia, and strabismus revealed a homozygous premature stop mutation at codon 139 of C12ORF65.
|
24080142 |
2013 |
Intellectual Disability
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Considering our findings, we now conclude that truncating mutations in C12ORF65 lead to a variable phenotype with intellectual disability, spastic paraplegia, and ophthalmoplegia as common symptoms.
|
24080142 |
2013 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analysis identifies 13 new risk loci for schizophrenia.
|
23974872 |
2013 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis identifies 13 new risk loci for schizophrenia.
|
23974872 |
2013 |